<table border="0" cellpadding="0" cellspacing="0" width="619" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9. Bioavailability of Divalproex Sodium Extended-Release Tablets Relative to Divalproex Sodium Delayed-Release Tablets When Divalproex Sodium Extended-Release Tablets Dose is 8 to 20% Higher</caption>
<thead>
<tr>
<th rowspan="2" stylecode="Lrule Rrule Toprule">Study Population</th>
<th align="center" stylecode="Lrule Rrule Toprule">Regimens</th>
<th align="center" colspan="3" stylecode="Lrule Rrule Toprule">Relative Bioavailability</th>
</tr>
<tr>
<th align="center" stylecode="Lrule Rrule Toprule">Divalproex Sodium Extended-Release Tablets vs. Divalproex Sodium  Delayed-Release Tablets 
                                                <br/>
<br/>
<br/>
<br/>
<br/>
</th>
<th align="center" stylecode="Lrule Rrule Toprule">AUC
                                                <sub>24</sub>
</th>
<th align="center" stylecode="Lrule Rrule Toprule">C
                                                <sub>max</sub>
</th>
<th align="center" stylecode="Lrule Rrule Toprule">C
                                                <sub>min</sub>
</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> Healthy Volunteers (N=35)
                                                <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1000 &amp; 1500 mg Divalproex Sodium Extended-Release Tablets vs. 875 &amp; 1250 mg Divalproex Sodium Delayed-Release Tablets 
                                                <br/>
<br/>
<br/>
<br/>
<br/>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1.059
                                                <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">0.882
                                                <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1.173
                                                <br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top"> Patients with epilepsy on concomitant enzyme-  inducing antiepilepsy drugs (N=64)
                                                <br/>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1000 to 5000 mg Divalproex Sodium Extended-Release Tablets vs. 875 to 4250 mg Divalproex Sodium Delayed-Release Tablets 
                                                <br/>
<br/>
<br/>
<br/>
<br/>
<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1.008
                                                <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">0.899
                                                <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">1.022
                                                <br/>
</td>
</tr>
</tbody>
</table>